Form 4 for BIO BIO-RAD LABORATORIES, INC.
Accepted 2025-09-03 00:00:00 ET · period of report 2025-09-01 · accession 0001976271-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-03 | 2025-09-01 | BIO | COREY COLLEEN | EVP, Gbl Human Resources | F - Tax | $297.88 | -398 | 19.2K | -2% | -$118.6K |
| D | 2025-09-03 | 2025-09-01 | BIO | COREY COLLEEN | EVP, Gbl Human Resources | M - OptEx | $0.00 | +1,102 | 19.6K | +6% | $0 |
| DM | 2025-09-03 | 2025-09-01 | BIO | COREY COLLEEN | EVP, Gbl Human Resources | M - OptEx | $0.00 | -1,102 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Bio-Rad A Common Stock | 2025-09-01 | F | D | 398 | $297.88 | 19,183 | D | — | — | |
| 2 | Common | Bio-Rad A Common Stock | 2025-09-01 | M | A | 1,102 | $0.00 | 19,581 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 3 | Derivative | Restricted Stock Units | 2025-09-01 | M | D | 501 | $0.00 | 1,002 | D | $0.00 · — to — | 501 Bio-Rad A Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F5) On September 1, 2023, the reporting person was granted 2,003 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 4 | Derivative | Restricted Stock Units | 2025-09-01 | M | D | 347 | $0.00 | 347 | D | $0.00 · — to — | 347 Bio-Rad A Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F4) On September 1, 2022, the reporting person was granted 1,388 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 5 | Derivative | Restricted Stock Units | 2025-09-01 | M | D | 254 | $0.00 | 0 | D | $0.00 · — to — | 254 Bio-Rad A Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F3) On September 1, 2021, the reporting person was granted 1,013 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |